• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Probable Association between Blood Groups and Prognosis of COVID-19.血型与新型冠状病毒肺炎预后之间的可能关联
Iran J Public Health. 2021 Apr;50(4):825-830. doi: 10.18502/ijph.v50i4.6009.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study.ABO 和 Rh 血型与 SARS-CoV-2 感染或严重 COVID-19 疾病的关联:一项基于人群的队列研究。
Ann Intern Med. 2021 Mar;174(3):308-315. doi: 10.7326/M20-4511. Epub 2020 Nov 24.
4
Does vitamin D serum level affect prognosis of COVID-19 patients?血清维生素 D 水平是否影响 COVID-19 患者的预后?
Int J Infect Dis. 2021 Jun;107:264-267. doi: 10.1016/j.ijid.2021.04.083. Epub 2021 Apr 30.
5
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
6
Association between ABO blood groups and rhesus antigen and susceptibility to COVID-19 in the Yazd hospital.亚兹德医院ABO血型、恒河猴抗原与COVID-19易感性之间的关联
New Microbes New Infect. 2021 Nov;44:100934. doi: 10.1016/j.nmni.2021.100934. Epub 2021 Sep 1.
7
Clinical Characteristics and Outcomes of Patients With Diabetes Admitted for COVID-19 Treatment in Dubai: Single-Centre Cross-Sectional Study.迪拜因 COVID-19 住院治疗的糖尿病患者的临床特征和结局:单中心横断面研究。
JMIR Public Health Surveill. 2020 Dec 7;6(4):e22471. doi: 10.2196/22471.
8
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
9
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.挪威 2019 年冠状病毒病(NO COVID-19)实用开放性标签研究,评估硫酸羟氯喹在 2019 年冠状病毒病中度重症住院患者中的早期使用:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.
10
Association of ABO and Rh Blood Group in Susceptibility, Severity, and Mortality of Coronavirus Disease 2019: A Hospital-Based Study From Delhi, India.ABO和Rh血型与2019冠状病毒病易感性、严重程度及死亡率的关联:一项来自印度德里的基于医院的研究
Front Cell Infect Microbiol. 2021 Nov 2;11:767771. doi: 10.3389/fcimb.2021.767771. eCollection 2021.

引用本文的文献

1
Changes in Pharmacological Approach to COVID-19 in a Referral Hospital in Tehran During Two Years.两年来德黑兰一家转诊医院对新冠肺炎治疗方法的变化
Tanaffos. 2024 Mar;23(3):250-255.
2
COVID 19 infection clinical features in pediatric patients in Southwestern Iran: a cross-sectional, multi-center study.伊朗西南部儿科患者的 COVID-19 感染临床特征:一项横断面、多中心研究。
BMC Infect Dis. 2023 Nov 25;23(1):828. doi: 10.1186/s12879-023-08720-z.
3
Frequency and distribution of ABO and Rh blood group systems among blood donors at the Northern Zone Blood Transfusion Center in Kilimanjaro, Tanzania: a retrospective cross-sectional study.坦桑尼亚乞力马扎罗北部地区血液中心献血者 ABO 和 Rh 血型系统的频率和分布:一项回顾性横断面研究。
BMJ Open. 2023 Feb 14;13(2):e068984. doi: 10.1136/bmjopen-2022-068984.
4
Does vitamin D serum level affect prognosis of COVID-19 patients?血清维生素 D 水平是否影响 COVID-19 患者的预后?
Int J Infect Dis. 2021 Jun;107:264-267. doi: 10.1016/j.ijid.2021.04.083. Epub 2021 Apr 30.

本文引用的文献

1
An Introduction to SARS Coronavirus 2; Comparative Analysis with MERS and SARS Coronaviruses: A Brief Review.严重急性呼吸综合征冠状病毒2简介;与中东呼吸综合征和严重急性呼吸综合征冠状病毒的比较分析:简要综述
Iran J Public Health. 2020 Oct;49(Suppl 1):30-37. doi: 10.18502/ijph.v49iS1.3667.
2
Associations between blood type and COVID-19 infection, intubation, and death.血型与 COVID-19 感染、插管和死亡之间的关联。
Nat Commun. 2020 Nov 13;11(1):5761. doi: 10.1038/s41467-020-19623-x.
3
The association between ABO blood group and SARS-CoV-2 infection: A meta-analysis.ABO 血型与严重急性呼吸综合征冠状病毒 2 感染的关系:荟萃分析。
PLoS One. 2020 Sep 18;15(9):e0239508. doi: 10.1371/journal.pone.0239508. eCollection 2020.
4
Relationship Between the ABO Blood Group and the Coronavirus Disease 2019 (COVID-19) Susceptibility.ABO 血型与 2019 年冠状病毒病(COVID-19)易感性的关系。
Clin Infect Dis. 2021 Jul 15;73(2):328-331. doi: 10.1093/cid/ciaa1150.
5
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors.法国 O 型血献血者中,中和 SARS-CoV-2 的抗体流行率较低。
Antiviral Res. 2020 Sep;181:104880. doi: 10.1016/j.antiviral.2020.104880. Epub 2020 Jul 15.
6
The COVID-19 Outbreak in Iran; The First Patient with a Definite Diagnosis.伊朗的 COVID-19 疫情爆发;首例明确诊断的患者。
Arch Iran Med. 2020 Jul 1;23(7):503-504. doi: 10.34172/aim.2020.48.
7
Blood type and outcomes in patients with COVID-19.COVID-19 患者的血型与结局。
Ann Hematol. 2020 Sep;99(9):2113-2118. doi: 10.1007/s00277-020-04169-1. Epub 2020 Jul 12.
8
Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19.ABO 血型分布与 COVID-19 患者临床特征的关系。
Clin Chim Acta. 2020 Oct;509:220-223. doi: 10.1016/j.cca.2020.06.026. Epub 2020 Jun 17.
9
Association between ABO blood groups and risk of SARS-CoV-2 pneumonia.ABO血型与新型冠状病毒肺炎风险之间的关联。
Br J Haematol. 2020 Jul;190(1):24-27. doi: 10.1111/bjh.16797. Epub 2020 May 26.
10
ABO blood group predisposes to COVID-19 severity and cardiovascular diseases.ABO血型易导致新冠病毒疾病的严重程度和心血管疾病。
Eur J Prev Cardiol. 2020 Sep;27(13):1436-1437. doi: 10.1177/2047487320922370. Epub 2020 Apr 28.

血型与新型冠状病毒肺炎预后之间的可能关联

The Probable Association between Blood Groups and Prognosis of COVID-19.

作者信息

Nasiri Maryam, Khodadadi Javad, Hajrezaei Zahra, Bizhani Negar

机构信息

Department of Infectious Diseases, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran.

Student Research Committee, School of Medicine, Qom University of Medical Sciences, Qom, Iran.

出版信息

Iran J Public Health. 2021 Apr;50(4):825-830. doi: 10.18502/ijph.v50i4.6009.

DOI:10.18502/ijph.v50i4.6009
PMID:34183933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8219630/
Abstract

BACKGROUND

We aimed to verify the association between blood group systems and prognosis of SARS-Cov-2 disease.

METHODS

In this cross-sectional study, 329 patients infected with SARS-Cov-2 diagnosed based on their COVID-19 RT-PCR results and chest CT scans, were enrolled in the study. These patients were admitted to Kamkar Arab Nia Hospital, Qom, Iran from March to June 2020. Their blood groups and RH were determined, and demographic characteristics and clinical signs of patients were recorded. The patients' temperature and peripheral capillary oxygen saturation levels (SpO2) were measured. Finally, the duration of hospitalization, intubation, and death rate were also analyzed.

RESULTS

The results of the patients' blood group analysis were as follows: 129(39.2%) patients had A type, 66(20.1%) B type, 21(6.4%) AB type, and 113(34.3%) O type. Of 329 patients, 297 (90.3%) had Rh antigen. The dead cases were higher in O blood type at 13 cases (11.5%). Considering the positive and negative rhesus antigen, 31 (10.4%) and 1 (3.1%) were dead respectively, but the difference was not statically significant. As for the A group, the mean of admission duration (8.4±6.1 days) was not significantly different from the B group (8.8 ±7.2 days). AB group with a mean (7.4 ±4.4 days) was not significantly different from the O group (7.8 ± 5.4 days). There was no significant difference in the duration of hospitalization in RH patients, positive or negative. B blood group showed a significant association with the time interval to return to normal oxygen levels.

CONCLUSION

Blood type was not associated with COVID-19 death rate, nor was it associated with admission duration. B blood group showed a significant association with the time interval to return to normal oxygen levels.

摘要

背景

我们旨在验证血型系统与新型冠状病毒肺炎(SARS-CoV-2)疾病预后之间的关联。

方法

在这项横断面研究中,纳入了329例根据其新冠病毒(COVID-19)逆转录聚合酶链反应(RT-PCR)结果和胸部CT扫描确诊感染SARS-CoV-2的患者。这些患者于2020年3月至6月被收治于伊朗库姆的卡姆卡尔阿拉伯尼亚医院。确定了他们的血型和Rh血型,并记录了患者的人口统计学特征和临床症状。测量了患者的体温和外周毛细血管血氧饱和度水平(SpO2)。最后,还分析了住院时间、插管情况和死亡率。

结果

患者血型分析结果如下:129例(39.2%)为A型,66例(20.1%)为B型,21例(6.4%)为AB型,113例(34.3%)为O型。在329例患者中,297例(90.3%)有Rh抗原。O型血的死亡病例数较高,为13例(11.5%)。考虑到Rh抗原阳性和阴性,分别有31例(10.4%)和1例(3.1%)死亡,但差异无统计学意义。至于A型组,平均住院时间(8.4±6.1天)与B型组(8.8±7.2天)无显著差异。AB型组平均(7.4±4.4天)与O型组(7.8±5.4天)无显著差异。Rh阳性或阴性患者的住院时间无显著差异。B型血与恢复正常血氧水平的时间间隔显示出显著关联。

结论

血型与COVID-19死亡率无关,也与住院时间无关。B型血与恢复正常血氧水平的时间间隔显示出显著关联。